Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Not yet recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

not_yet_recruiting120%
completed240%
unknown120%
terminated120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study)

NCT07192315
unknown

Genome-wide Epistasis for Cardiovascular Severity in Marfan Study

NCT06257004
terminatednot_applicable

Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

NCT01491854
completed

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

NCT01621425
completed

Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study

NCT00878813

Clinical Trials (5)

Showing 5 of 5 trials
NCT07192315Not Applicable

Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study)

Not Yet Recruiting
NCT06257004

Genome-wide Epistasis for Cardiovascular Severity in Marfan Study

Unknown
NCT01491854Not Applicable

Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

Terminated
NCT01621425

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

Completed
NCT00878813

Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5